The skin in the gym: a comprehensive review of the cutaneous manifestations of community-acquired methicillin-resistant Staphylococcus aureus infection in athletes

Clinics in Dermatology

Volumn 26, Issue 1, 2008, Pages 16-26

  Cohen, Philip R ^a,b,c  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CEFTRIAXONE; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALBAVANCIN; DAPTOMYCIN; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; ORITAVANCIN; QUINUPRISTIN; RIFAMPICIN; TEICOPLANIN; TELAVANCIN; TETRACYCLINE; TIGECYCLINE; TRICLOSAN; VANCOMYCIN;

ARTICLE; ATHLETE; COMMUNICABLE DISEASE; EPIDEMIC; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHYSICAL EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN DISEASE; SKIN INFECTION;

ABSCESS; ADULT; ANTI-BACTERIAL AGENTS; CELLULITIS; COMMUNITY-ACQUIRED INFECTIONS; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; RISK FACTORS; SKIN; SKIN CARE; SPORTS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 38949190211     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2007.10.006     Document Type: Article

References (66)

1. Cohen P.R., and Grossman M.E. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. [Commentary]. J Am Acad Dermatol 51 (2004) 132-135
2. Young D.M., Harris H.W., Charlebois E.D., et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 139 (2004) 947-953
3. Chambers H.F. Community-associated MRSA-resistance and virulence converge. [editorial]. N Engl J Med 352 (2005) 1485-1487
4. Crawford S.E., and Daum R.S. Epidemic community-associated methicillin-resistant Staphylococcus aureus. Modern times for an ancient pathogen. Pediatr Infect Dis J 24 (2005) 459-460
5. Purcell K., and Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections. A 14-year study at Driscoll children's hospital. Arch Pediatr Adolesc Med 159 (2005) 980-985
6. Gosbell I.B. Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA). Intern Med J 35 (2005) S120-S135
7. Kowalski T.J., Berbari E.F., and Osmon D.R. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc 80 (2005) 1201-1208
8. Weber J.T. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 41 (2005) S269-S272
9. Beilman G.J., Sandifer G., Skarda D., et al. Emerging infections with community-associated methicillin-resistant Staphylococcus aureus in outpatients at an army community hospital. Surg Infect 6 (2005) 87-92
10. Elston D.M. Optimal antibacterial treatment of uncomplicated skin and skin structure infections: applying a novel treatment algorithm. J Drugs Dermatol 4 (2005) s15-s19
11. Maltin L.J. Share and share alike-except in locker room. WebMD with AOL Health. [Accessed 06 September 2004]. Available from (2004). http://aolsvc.health.webmd.aol.com/content/article/36/1676_52814.htm
12. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles county, 2000-2003. MMWR Morb Mortal Wkly Rep 52 (2003) 793-795
13. Cohen P.R., and Kurzrock R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J Am Acad Dermatol 50 (2004) 277-280
14. Cohen P.R. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. South Med J 98 (2005) 596-602
15. Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles county, California, 2002-2003. MMWR Morb Mortal Wkly Rep 52 (2003) 88
16. Nguyen D.M., Mascola L., and Bancroft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 11 (2005) 526-532. 2005 Apr [Accessed 14 November 2007]. Available from http://www.cdc.gov/ncidod/EID/vol11no04/04-1094.htm
17. Arlinghaus E., Hann M.J., and Nguyen A.-D. Community acquired methicillin resistant Staphylococcus aureus in an athletic environment. Case Poster Presentation [Accessed 14 November 2007]. Available from (2004). http://www1.ncaa.org/membership/ed_outreach/health-safety/healthcare/sports_med_education/MRSAposter.pdf
18. Begier E.M., Frenette K., Barrett N.L., et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 39 (2004) 1446-1453
19. Schindehette S., Morehouse M., and Erwin S. Killer microbe. People 63 (2005) 133-134
20. Mihoces G. Sports teams warned about unique skin infection. USA Today (2003). http://www.usatoday.com/sports/2003-10-14-sports-infections_x.htm [Accessed 22 December 2005]. Available from
21. Blauvelt H. High school team hit with MRSA. [online]. USA Today (2003). [Accessed 14 November 2007]. Available from http://www.usatoday.com/sports/preps/football/2003-10-15-skin-disease_x.htm
22. Dominguez T.J. It's not a spider bite, it's community-acquired methicillin-resistant Staphylococcus aureus. J Am Board Fam Pract 17 (2004) 220-226
23. Rihn J.A., Posfay-Barbe K., Harner C.D., et al. Community-acquired methicillin-resistant Staphylococcus aureus outbreak in a local high school football team unsuccessful interventions. Pediatr Infect Dis J 24 (2005) 841-843
24. Borchardt S.M., Yoder J.S., and Dworkin M.S. Is the recent emergence of community-associated methicillin-resistant Staphylococcus aureus among participants in competitive sports limited to participants?. [letter]. Clin Infect Dis 40 (2004) 906-907
25. Srinivasan A., and Kazakova S. The bigger they are, the harder they fall: methicillin-resistant Staphylococcus aureus skin and soft tissue infections among professional football players-2003. [abstract #383]. Presented at the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; Philadelphia, Pennsylvania; Apr 17-20 (2004)
26. Kazakova S.V., Hageman J.C., Matava M., et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352 (2005) 468-475
27. Lindenmayer J.M., Schoenfeld S., O'Grady R., and Carney J.K. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 158 (1998) 895-898
28. Stacey A.R., Endersby K.E., Chan P.C., and Marples R.R. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med 32 (1998) 153-154
29. Takizawa Y., Taneike I., Nakagawa S., et al. A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol 43 (2005) 3356-3363
30. Goodman R.A., Thacker S.B., Solomon S.L., Osterholm M.T., and Hhughes J.M. Infectious diseases in competitive sports. JAMA 271 (1994) 862-867
31. Cohen P.R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as an axillary abscess with cellulitis in a college athlete. SKINmed: Dermatology for the Clinician 4 (2005) 115-118
32. Cohen P.R. What caused this abscess and cellulitis? Diagnosis: community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) skin infection. Skin & Aging 12 (2004) 56-58
33. Cohen PR. Enlarging facial abscess with cellulitis (community-acquired methicillin-resistant Staphylococcus aureus [Dermatology Dx]. Cortlandt Forum 2005;18:42,45.
34. Cohen PR. Enlarging facial abscess with cellulitis (community-acquired methicillin-resistant Staphylococcus aureus [Dermatology Clinic]. Clin Advis 2005;8:60, 63.
35. Cohen P.R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as a periumbilical folliculitis: case reports. Cutis 77 (2006) 229-232
36. Fagan S.P., Berger D.H., Rahwan K., and Awad S.S. Spider bites presenting with methicillin-resistant Staphylococcus aureus soft tissue infection require early aggressive treatment. Surg Infect 4 (2003) 311-315
37. Miller L.G., and Spellberg B. Spider bites and infections caused by community-associated methicillin-resistant Staphylococcus aureus. [letter]. Surg Infect 5 (2004) 321-322
38. Center for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities-Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 52 (2003) 992-996
39. Tripoli L., and Bick J. HIV Education Prison Project (HEEP) news-spotlight: methicillin-resistant Staphylococcus aureus (MRSA). Aegis 6 (2003). [Accessed 14 November 2007]. Available from: www.aegis.com (Publications: Professional: HIV Educational Prison Project Report: 2003 Publications)
40. Arkwright P.D., Daniel T.O., Sanyal D., David T.J., and Patel L. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center. Arch Dermatol 138 (2002) 939-941
41. Lee M.C., Rios A.M., Aten M.F., et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 23 (2004) 123-127
42. Cohen P.R. Empiric treatment of skin infections. Dr. Cohen responds. [letter]. Clin Advis 9 (2006) 11-12
43. Rios A.M., Lee M.C., and Hardy R.D. Staphylococcal skin infections. Reply. [letter]. Pediatr Infect Dis J 23 (2004) 795-796
44. Miller L.G., and Spellberg B. Treatment of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections with drainage but no antibiotic therapy. [letter]. Pediatr Infect Dis J 23 (2004) 795
45. Faden H. Staphylococcal skin infections. [letter]. Pediatr Infect Dis J 23 (2004) 690
46. Moran G.J., and Talan D.A. Community-associated methicillin-resistant Staphylococcus aureus: is it in your community and should it change practice?. [editorial]. Ann Emerg Med 45 (2005) 321-322
47. Moran G.J., Amii R.N., Abrahamian F.M., and Talan D.A. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 11 (2005) 928-930. Available from: www.cdc.gov/eid
48. Grim S.A., Rapp R.P., Martin C.A., and Evans M.E. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Pharmacotherapy 25 (2005) 253-264
49. Kaplan S.L. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 24 (2005) 457-458
50. Ladhani S., and Garbash M. Staphylococcal skin infections in children. Rational drug therapy recommendations. Paediatr Drugs 7 (2005) 77-102
51. Ellis M.W., and Lewis II J.S. Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis 18 (2005) 496-501
52. Ruhe J.J., Monson T., Bradsher R.W., and Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 40 (2005) 1429-1434
53. Rybak M.J., and LaPlante K.L. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 25 (2005) 74-85
54. Bradley J.S. Newer antistaphylococcal agents. Curr Opin Pediatr 17 (2005) 71-77
55. Ashourian N., and Cohen P.R. Systemic antibacterial agents (Chapter 4). In: Wolverton S.E. (Ed). Comprehensive dermatologic drug therapy. 2nd edition (2007), WB Saunders Company, Philadelphia, PA 39-74
56. Zafar A.B., Butler R.C., Reese D.J., Gaydos L.A., and Mennonna P.A. Use of 0.3% triclosan (Bacti-Stat*) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 23 (1995) 200-208
57. Bartzokas C.A., Paton J.H., Gibson M.F., Graham R., McLoughlin C.A., and Croton R.S. Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit. N Engl J Med 311 (1984) 1422-1425
58. Dryden M.S., Dailly S., and Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 56 (2004) 283-286
59. Texas Department of State Health Services, Infection Disease Control Unit. Information on staphylococcal infections for school athletic departments. [Accessed 14 November 2007]. Available from:. http://www.dshs.state.tx.us/idcu/health/antibiotic_resistance/mrsa/
60. Jones R.S. Expert advice on erasing the MRSA threat. Pract Dermatol 2 (2005) 33-37
61. Cohen P.R. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am J Clin Dermatol 8 (2007) 259-270
62. Centers for Disease Control and Prevention. CDC suggests prevention measures for community-acquired MRSA infection. [Accessed 14 November 2007]. Available from:. http://www1.ncaa.org/membership/ed_outreach/health-safety/healthcare/sports_med_education/CDC_preventionmeasures.pdf
63. Howe W.B. Preventing infectious disease in sports. Phys Sportsmed 31 (2003). http://www.physsportsmed.com/issues/2003/0203/howe.htm Available from: http://www.physsportsmed.com/issues/2003/0203/howe.htm
64. Rieger D., and Bick J. HIV Education Prison Project (HEEP) report-spotlight: so your facility has CA-MRSA. The body: the complete HIV/AIDS. Resource 7 (2004). http://www.thebody.com/hepp/julaug04/spotlight.html [Accessed 14 April 2005]. Available from:
65. Cohen P.R. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection: a personal perspective of a world-wide epidemic. [editorial]. Expert Rev Dermatol 1 (2006) 631-637. http://www.future-drugs.com/doi/pdf/10.1586/17469872.1.5.631
66. Cohen P.R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a review of epidemiology, clinical features, management, and prevention. Int J Dermatol 46 (2007) 1-11